Remove 2025 Remove Hemorrhage Remove Hypertension
article thumbnail

Abstract DP50: Angiotensin inhibition reduces the risk of subarachnoid hemorrhage in patients with hypertension

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ADP50-ADP50, February 1, 2025. Background:Local angiotensin activity is thought to play a critical role in arterial wall homeostasis and remodeling, which contributes to the pathogenesis of subarachnoid hemorrhage (SAH). million patients with hypertension were assessed. female) [HR:0.94(0.91-0.97),

article thumbnail

Abstract WP230: Neuroinflammation Biomarker in the Course and Prognosis of Hemorrhagic Strokes

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP230-AWP230, February 1, 2025. Hemorrhagic strokes (HS) are increasingly significant causes of disability and mortality worldwide, making the use of blood biomarkers for their diagnosis and prognosis critical.

article thumbnail

Abstract 83: Prognostic Value of Cortical Superficial Siderosis Among Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page A83-A83, February 1, 2025. Introduction:The recent update (version 2.0) Introduction:The recent update (version 2.0) Lobar CMBs occurred in 326 (51%) patients, cSS occurred in 197 (31%), multispot WMH pattern occurred in 123 (19%), and severe centrum semiovale EPVS occurred in 156 (24%).

article thumbnail

Abstract TP170: White Matter Disease Burden Not Independently Associated with Clinical Outcomes or Hemorrhagic Transformation in DEFUSE 3 Population

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP170-ATP170, February 1, 2025. Introduction:Cerebrovascular white matter disease (WMD) severity is linked to vascular risk factors like hypertension, hyperlipidemia, and diabetes. In stroke, it has been associated with infarct growth, hemorrhagic transformation, and poor outcomes.

article thumbnail

Abstract TP189: Statin Therapy and Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis of Mortality Risk

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP189-ATP189, February 1, 2025. Contributing factors such as hypocholesterolemia and hypertension amplify the risk of ICH and subsequent hematoma expansion, underscoring the urgent need for effective interventions. and a 95% confidence interval (CI) of 0.25-0.57 0.57 (p < 0.00001).

article thumbnail

Abstract NS7: Time is Brain and Team is Brain! A Partnership to Improve Blood Pressure Control for Hemorrhagic Stroke Patients

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ANS7-ANS7, February 1, 2025. Background and Purpose:Intracerebral and subarachnoid hemorrhages comprise roughly 15% of all strokes but have a higher risk of mortality and morbidity than ischemic strokes.

article thumbnail

Abstract 49: Genomic Profiling and Risk of Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Apixaban

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025. Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH.